Answers are grounded in this paper and cite their sources.
Previous assessments of stem cell therapy for spinal cord injuries (SCI) have encountered challenges and constraints. Current research primarily emphasizes safety in early-phase clinical trials, while systematic reviews prioritize effectiveness, often overlooking safety and translational feasibility. This situation prompts inquiries regarding the readiness for clinical adoption.
No takes yet. Share an insight, caveat, or question.
Agosti et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: